AC Camargo Cancer Center | International Research Center (CIPE)

Research site
R. Tagua, 440, Liberdade, Sao Paulo, Sao Paulo, Brazil
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


2 of 5
Status: Active
Trial type: Interventional
Funder type: Industry

A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors

TAK-981 is being tested in combination with pembrolizumab to treat participants who have select advanced or metastatic solid tumors.The study aims ar...

Active, not recruiting
Advanced or Metastatic Solid Tumors
Drug: Pembrolizumab
Drug: TAK-981

The main objective of Part 1 is to evaluate the safety and tolerability of bemarituzumab plus 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6)...

Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Other: Placebo
Drug: Nivolumab

Trial conditions

Stomach Cancer (2 trials)
Adenocarcinoma (1 trial)
Breast Cancer (1 trial)
Endometrial Cancer (1 trial)
Esophageal Cancer (1 trial)
Gastritis (1 trial)
Lymphatic Metastasis (1 trial)
Metaplasia (1 trial)
Cancer (1 trial)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems